CRISPR Therapeutics AG: Form 8-K, filed Feb 13, 2024
Filed with the SEC on Feb 13, 2024 and accepted by EDGAR at Feb 13, 2024, 06:30 ET.
Items reported
- Item 8.01 Other events
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-24-032825. Last ingested by Listed: Nov 6, 2026, 18:37 ET. Listed shows no prices and gives no investment advice.